| Meet the University of Wisconsin-Madison’s Quanyin Hu Assistant Professor of Pharmacy School of Pharmacy |
 |
Research area Drug delivery, facilitating translational research by combining cell therapy, immunotherapy and personalized therapy. Developed a sequential coating strategy to improve the efficacy of probiotics used in the treatment of IBD; a biodegradable gel that improves the immune system’s ability to keep cancer at bay after tumors are surgically removed; and an immunity-boosting postoperative treatment that could transform the odds for patients with glioblastoma.
What excites you about your work?
“Our motivation for our research is to translate our technology into patient care. We are trying to connect clinical applications and scientific discovery to help deliver better therapeutics directly to disease sites to minimize side effects and improve patient prognosis. Ultimately, we are trying to improve the application and translation of scientific discovery on therapeutics.”
What do you hope to achieve?
“We want to develop a basic drug delivery system with enhanced efficacy and minimal toxicity. We are working toward clinical trials of our drug delivery systems, and we want to contribute to the discovery of new therapeutics. When we design our projects, we always think about the patient first and designing delivery system that can have real impacts on patients.”
We are excited about Quanyin’s technology and some of the novel approaches he is developing in his lab. We expect to continue working with him and supporting his efforts to bring these novel approaches to market.
– Rafael Diaz, WARF, Licensing Manager
Want to learn more?
Rafael Diaz, [email protected], 608.960.9847